163 related articles for article (PubMed ID: 33616382)
1. Antibiotic Cross-linked Micelles with Reduced Toxicity for Multidrug-Resistant Bacterial Sepsis Treatment.
Yang X; Ren H; Zhang H; Liu G; Jiang Z; Qiu Q; Yu C; Murthy N; Zhao K; Lovell JF; Zhang Y
ACS Appl Mater Interfaces; 2021 Mar; 13(8):9630-9642. PubMed ID: 33616382
[TBL] [Abstract][Full Text] [Related]
2. Traceless antibiotic-crosslinked micelles for rapid clearance of intracellular bacteria.
Yang X; Qiu Q; Liu G; Ren H; Wang X; Lovell JF; Zhang Y
J Control Release; 2022 Jan; 341():329-340. PubMed ID: 34843813
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates.
Jahangiri A; Neshani A; Mirhosseini SA; Ghazvini K; Zare H; Sedighian H
Microb Pathog; 2021 Jan; 150():104700. PubMed ID: 33346078
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of antimicrobial peptide CDP-B11 alone and in combination with colistin against colistin-resistant and multidrug-resistant Escherichia coli.
Witherell KS; Price J; Bandaranayake AD; Olson J; Call DR
Sci Rep; 2021 Jan; 11(1):2151. PubMed ID: 33495505
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models.
Parra Millán R; Jiménez Mejías ME; Sánchez Encinales V; Ayerbe Algaba R; Gutiérrez Valencia A; Pachón Ibáñez ME; Díaz C; Pérez Del Palacio J; López Cortés LF; Pachón J; Smani Y
Antimicrob Agents Chemother; 2016 Aug; 60(8):4464-70. PubMed ID: 27161639
[TBL] [Abstract][Full Text] [Related]
8. Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant
Konai MM; Haldar J
ACS Infect Dis; 2020 Jan; 6(1):91-99. PubMed ID: 31646866
[TBL] [Abstract][Full Text] [Related]
9. Synergistic combinations of anthelmintic salicylanilides oxyclozanide, rafoxanide, and closantel with colistin eradicates multidrug-resistant colistin-resistant Gram-negative bacilli.
Domalaon R; Okunnu O; Zhanel GG; Schweizer F
J Antibiot (Tokyo); 2019 Aug; 72(8):605-616. PubMed ID: 31028351
[TBL] [Abstract][Full Text] [Related]
10. Synergistic efficacy of meropenem and rifampicin in a murine model of sepsis caused by multidrug-resistant Acinetobacter baumannii.
Sun Y; Wang L; Li J; Zhao C; Zhao J; Liu M; Wang S; Lu C; Shang G; Jia Y; Wen A
Eur J Pharmacol; 2014 Apr; 729():116-22. PubMed ID: 24561048
[TBL] [Abstract][Full Text] [Related]
11. Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis.
De Oliveira DMP; Bohlmann L; Conroy T; Jen FE; Everest-Dass A; Hansford KA; Bolisetti R; El-Deeb IM; Forde BM; Phan MD; Lacey JA; Tan A; Rivera-Hernandez T; Brouwer S; Keller N; Kidd TJ; Cork AJ; Bauer MJ; Cook GM; Davies MR; Beatson SA; Paterson DL; McEwan AG; Li J; Schembri MA; Blaskovich MAT; Jennings MP; McDevitt CA; von Itzstein M; Walker MJ
Sci Transl Med; 2020 Nov; 12(570):. PubMed ID: 33208501
[TBL] [Abstract][Full Text] [Related]
12. Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections.
Phee LM; Betts JW; Bharathan B; Wareham DW
Antimicrob Agents Chemother; 2015 Aug; 59(8):4544-50. PubMed ID: 25987639
[TBL] [Abstract][Full Text] [Related]
13. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
Hu YF; Liu CP; Wang NY; Shih SC
BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
[TBL] [Abstract][Full Text] [Related]
14. Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis.
Cirioni O; Simonetti O; Pierpaoli E; Barucca A; Ghiselli R; Orlando F; Pelloni M; Trombettoni MM; Guerrieri M; Offidani A; Giacometti A; Provinciali M
Diagn Microbiol Infect Dis; 2016 Dec; 86(4):392-398. PubMed ID: 27712928
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the in vitro colistin susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii strains at a tertiary care centre in Western Turkey.
Ece G; Samlioglu P; Atalay S; Kose S
Infez Med; 2014 Mar; 22(1):36-40. PubMed ID: 24651089
[TBL] [Abstract][Full Text] [Related]
16. A traceless reversible polymeric colistin prodrug to combat multidrug-resistant (MDR) gram-negative bacteria.
Zhu C; Schneider EK; Wang J; Kempe K; Wilson P; Velkov T; Li J; Davis TP; Whittaker MR; Haddleton DM
J Control Release; 2017 Aug; 259():83-91. PubMed ID: 28174100
[TBL] [Abstract][Full Text] [Related]
17. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
[TBL] [Abstract][Full Text] [Related]
18. The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.
Ceccarelli G; Oliva A; d'Ettorre G; D'Abramo A; Caresta E; Barbara CS; Mascellino MT; Papoff P; Moretti C; Vullo V; Visca P; Venditti M
BMC Infect Dis; 2015 Sep; 15():393. PubMed ID: 26424078
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
[TBL] [Abstract][Full Text] [Related]
20. The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli.
Domalaon R; De Silva PM; Kumar A; Zhanel GG; Schweizer F
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
